Navigation Links
Pfenex Inc. Launches reagentproteins.com
Date:11/2/2010

SAN DIEGO, Nov. 2, 2010 /PRNewswire/ -- Pfenex Inc. today announced the launch of a new business division, Reagent Proteins. Reagent Proteins will enhance the development scientists' ability to source complex reagent grade proteins at a competitive price.

Reagent Proteins will initially offer a product list in excess of 2300 proteins, including stem cell growth factors, cytokines, chemokines, and enzymes. A unique aspect of Reagent Proteins' offering includes vaccine carriers, adjuvants and antigens, available in both pre-clinical and cGMP quality grades. Reagent Proteins is the only protein supplier supporting human vaccine developers from discovery to commercialization with a broad range of vaccine components.

"As we continue to leverage our business based on efficient complex protein production, the Reagent Proteins business unit is an obvious choice," stated Bertrand C. Liang, Chief Executive Officer, "We have and continue to build a portfolio of proteins in areas of need, including those based upon monitoring of industry trends as well as direct feedback from the researchers themselves."

About Reagent Proteins

Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high quality proteins to enable their development efforts to proceed efficiently. www.reagentproteins.com

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
2. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
3. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
4. CoreLab Partners Launches New DXA Imaging Service Offerings
5. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
6. InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
7. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
8. HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums
9. Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
10. Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
11. West Michigan Launches $10 Million Early Stage Venture Fund to Support Life Science & Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology:
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/16/2017)... - Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... ...
Breaking Biology News(10 mins):